MannKind Corp (MNKD)-医療機器分野:企業M&A・提携分析

◆英語タイトル:MannKind Corp (MNKD) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011070
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MannKind Corp (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes. The company’s lead product, Afrezza is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. It also developed a line of breath-powered, dry powder inhalers. Mannkind develops its products based on Technosphere drug delivery platform, its proprietary formulation technology. It also utilizes inhalation profiling technologies such as BluHale. It conducts its manufacturing operations in Danbury, Connecticut and sells its products in the US through a direct sales force. MannKind is headquartered in California, the US.

MannKind Corp (MNKD) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
MannKind Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
MannKind Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
MannKind Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
MannKind Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
MannKind Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
MannKind Corp, Medical Equipment, Deal Details 11
Partnerships 11
MannKind and One Drop to Enter into Agreement 11
Equity Offering 12
Mannkind to Raise USD61 Million in Private Placement of Shares 12
MannKind Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 14
MannKind Raises USD36.2 Million in Private Placement of Shares 15
Mannkind Raises USD50 Million in Private Placment of Shares 16
MannKind Announces Public Offering Of Common Stock For US$50 Million 18
MannKind Completes Public Offering Of Common Stock And Warrants For US$92 Million 19
MannKind Completes Public Offering Of Units For US$86 Million 20
Debt Offering 22
MannKind Completes First Tranche Of Private Placement Of Notes For US$40 Million 22
MannKind Plans Public Offering Of Senior Secured Discount Notes Due 2017 For US$370 Million 24
MannKind Corp – Key Competitors 25
MannKind Corp – Key Employees 26
MannKind Corp – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Strategy And Business Planning 28
Sep 05, 2017: MannKind Relocates Headquarters to Westlake Village 28
Financial Announcements 29
Aug 07, 2017: MannKind Reports 2017 Second Quarter Financial Results 29
May 10, 2017: MannKind Reports 2017 First Quarter Financial Results 31
Mar 16, 2017: MannKind Reports 2016 Fourth Quarter and Full Year Financial Results 32
Nov 09, 2016: MannKind Reports 2016 Third Quarter Financial Results 34
Aug 08, 2016: MannKind Reports 2016 Second Quarter Financial Results 36
May 09, 2016: MannKind Reports 2016 First Quarter Financial Results 37
Mar 14, 2016: MannKind Reports 2015 Fourth Quarter and Full Year Financial Results 38
Corporate Communications 39
Jul 17, 2017: Steven Binder Joins MannKind as Chief Financial Officer 39
Jul 12, 2017: Patrick McCauley Joins MannKind as Chief Commercial Officer 40
Jun 28, 2017: Mannkind draws remaining funds under mann group loan arrangement 41
Jan 04, 2017: MannKind Announces Key Addition to Its Executive Management Ranks 42
Apr 19, 2016: MannKind Expands Commercial Capabilities With Two New Hires 43
Mar 14, 2016: MannKind Announces Appointment of Michael Castagna as Chief Commercial Officer 44
Feb 19, 2016: Alfred Mann Steps Down as Executive Chairman of Mannkind 45
Jan 11, 2016: MannKind Provides Update on Senior Management 46
Other Significant Developments 47
Jan 03, 2017: MannKind Receives $1 Million Milestone From RLS 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
MannKind Corp, Medical Equipment, Key Facts, 2016 2
MannKind Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
MannKind Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
MannKind Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 7
MannKind Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
MannKind Corp, Deals By Market, 2011 to YTD 2017 9
MannKind Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
MannKind and One Drop to Enter into Agreement 11
Mannkind to Raise USD61 Million in Private Placement of Shares 12
MannKind Plans to Raise Funds through Private Placement of Shares upon Exercise of Warrants 14
MannKind Raises USD36.2 Million in Private Placement of Shares 15
Mannkind Raises USD50 Million in Private Placment of Shares 16
MannKind Announces Public Offering Of Common Stock For US$50 Million 18
MannKind Completes Public Offering Of Common Stock And Warrants For US$92 Million 19
MannKind Completes Public Offering Of Units For US$86 Million 20
MannKind Completes First Tranche Of Private Placement Of Notes For US$40 Million 22
MannKind Plans Public Offering Of Senior Secured Discount Notes Due 2017 For US$370 Million 24
MannKind Corp, Key Competitors 25
MannKind Corp, Key Employees 26
MannKind Corp, Other Locations 27

★海外企業調査レポート[MannKind Corp (MNKD)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BDO Unibank Inc:企業の戦略・SWOT・財務情報
    BDO Unibank Inc - Strategy, SWOT and Corporate Finance Report Summary BDO Unibank Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Welspun India Ltd (WELSPUNIND):企業の財務・戦略的SWOT分析
    Welspun India Ltd (WELSPUNIND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Illumina Inc (ILMN):企業の財務・戦略的SWOT分析
    Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Rockwool International AS:戦略・SWOT・企業財務分析
    Rockwool International AS - Strategy, SWOT and Corporate Finance Report Summary Rockwool International AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Arlington Asset Investment Corp (AI):企業の財務・戦略的SWOT分析
    Summary Arlington Asset Investment Corp (AAIC) is an investment firm that offers asset management and investment services. The firm acquires and holds mortgage-related assets. It acquires residential mortgage-backed securities issued by the US government agencies. AAIC also acquires mortgage-backed …
  • Henry Schein Inc (HSIC)-製薬・医療分野:企業M&A・提携分析
    Summary Henry Schein, Inc. (Henry Schein) is a distributor of healthcare products and services. Its product and service portfolio consists of dental products, medical products, animal health products, software and technology and other value-added services. It offers generic and branded pharmaceutica …
  • Ambac Financial Group, Inc.:企業の戦略・SWOT・財務分析
    Ambac Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ambac Financial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • GVK Biosciences Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary GVK Biosciences Pvt Ltd (GVK BIO) is a contract research organization that offers contract manufacturing and research services. The organization provides services such as discovery services, integrated programs, clinical development, contract manufacturing, formulations and informatics. It p …
  • Huntsman Corp (HUN):企業の財務・戦略的SWOT分析
    Huntsman Corp (HUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sino Oil and Gas Holdings Ltd (702):石油・ガス:M&Aディール及び事業提携情報
    Summary Sino Oil and Gas Holdings Ltd (Sino Oil and Gas), formerly Genesis Energy Holdings Ltd, is an oil and gas company that offers production and development of oil properties. The company offers services such as oil and gas exploration, production, distribution, development and supplying service …
  • Bureau Veritas SA:企業の戦略・SWOT・財務情報
    Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report Summary Bureau Veritas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Malayan Banking Berhad:企業の戦略・SWOT・財務情報
    Malayan Banking Berhad - Strategy, SWOT and Corporate Finance Report Summary Malayan Banking Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Royal KPN N.V.:企業の戦略・SWOT・財務情報
    Royal KPN N.V. - Strategy, SWOT and Corporate Finance Report Summary Royal KPN N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Tragara Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tragara Pharmaceuticals Inc (Tragara Pharmaceuticals) is a pharmaceutical company focused on the clinical and commercial development of its proprietary medicines for the treatment of various cancers. Its lead product candidate TG02, an oral multi-kinase inhibitor facilitates anti-tumor activ …
  • Swinerton Inc:企業の戦略的SWOT分析
    Swinerton Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • EVN AG (EVN)-エネルギー分野:企業M&A・提携分析
    Summary EVN AG (EVN) is an energy and environmental services company. It provides electricity, natural gas, heat, drinking water, wastewater treatment, thermal waste utilization, and related services. The company produces power from thermal and renewable sources. EVN procures electricity, natural ga …
  • Marathon Petroleum Corporation:企業の戦略・SWOT・財務情報
    Marathon Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary Marathon Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Medipines Corp-医療機器分野:企業M&A・提携分析
    Summary MediPines Corp (Medipines) develops and commercializes advanced respiratory measurement and monitoring devices. It focuses on the development of portable and non-invasive devices based on pulse oximetry technology. The company’s lead product candidate, Oxistimulator, is a respiratory depress …
  • Fraser & Neave Holdings Bhd:企業の戦略・SWOT・財務情報
    Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report Summary Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Aslan Pharmaceuticals Pte Ltd:企業のM&A・事業提携・投資動向
    Aslan Pharmaceuticals Pte Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aslan Pharmaceuticals Pte Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆